These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 21443940)
21. Upflow anaerobic sludge blanket reactor--a review. Bal AS; Dhagat NN Indian J Environ Health; 2001 Apr; 43(2):1-82. PubMed ID: 12397675 [TBL] [Abstract][Full Text] [Related]
22. Antibody therapeutics, antibody engineering, and the merits of protein stability. Demarest SJ; Glaser SM Curr Opin Drug Discov Devel; 2008 Sep; 11(5):675-87. PubMed ID: 18729019 [TBL] [Abstract][Full Text] [Related]
23. Minimalist active-site redesign: teaching old enzymes new tricks. Toscano MD; Woycechowsky KJ; Hilvert D Angew Chem Int Ed Engl; 2007; 46(18):3212-36. PubMed ID: 17450624 [TBL] [Abstract][Full Text] [Related]
24. Pharmaceutical and industrial protein engineering: where we are? Amara AA Pak J Pharm Sci; 2013 Jan; 26(1):217-32. PubMed ID: 23261751 [TBL] [Abstract][Full Text] [Related]
26. Engineering proteins with tunable thermodynamic and kinetic stabilities. Pey AL; Rodriguez-Larrea D; Bomke S; Dammers S; Godoy-Ruiz R; Garcia-Mira MM; Sanchez-Ruiz JM Proteins; 2008 Apr; 71(1):165-74. PubMed ID: 17932922 [TBL] [Abstract][Full Text] [Related]
27. Antibody engineering and modification technologies. Filpula D Biomol Eng; 2007 Jun; 24(2):201-15. PubMed ID: 17466589 [TBL] [Abstract][Full Text] [Related]
28. Creating the next generation of protein therapeutics through rational drug design. Szymkowski DE Curr Opin Drug Discov Devel; 2005 Sep; 8(5):590-600. PubMed ID: 16159021 [TBL] [Abstract][Full Text] [Related]
29. Bioactive proteinaceous hydrogels from designed bifunctional building blocks. Wheeldon IR; Barton SC; Banta S Biomacromolecules; 2007 Oct; 8(10):2990-4. PubMed ID: 17887795 [TBL] [Abstract][Full Text] [Related]
30. Monoclonal antibodies as targeting and therapeutic agents: prospects for liver transplantation, hepatitis and hepatocellular carcinoma. Luk JM; Wong KF Clin Exp Pharmacol Physiol; 2006; 33(5-6):482-8. PubMed ID: 16700883 [TBL] [Abstract][Full Text] [Related]
31. Intravail: highly effective intranasal delivery of peptide and protein drugs. Maggio ET Expert Opin Drug Deliv; 2006 Jul; 3(4):529-39. PubMed ID: 16822227 [TBL] [Abstract][Full Text] [Related]
39. Engineering a pharmacologically superior form of granulocyte-colony-stimulating factor by fusion with gelatin-like-protein polymer. Huang YS; Wen XF; Wu YL; Wang YF; Fan M; Yang ZY; Liu W; Zhou LF Eur J Pharm Biopharm; 2010 Mar; 74(3):435-41. PubMed ID: 19995603 [TBL] [Abstract][Full Text] [Related]
40. Enhancement of therapeutic protein in vivo activities through glycoengineering. Elliott S; Lorenzini T; Asher S; Aoki K; Brankow D; Buck L; Busse L; Chang D; Fuller J; Grant J; Hernday N; Hokum M; Hu S; Knudten A; Levin N; Komorowski R; Martin F; Navarro R; Osslund T; Rogers G; Rogers N; Trail G; Egrie J Nat Biotechnol; 2003 Apr; 21(4):414-21. PubMed ID: 12612588 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]